# Early Week 2 Response Predicts Sustained Benefit with Adjunct Cariprazine in MDD

- URL: https://theranews.net/blog/2026-01-06-early-week-2-response-predicts-sustained-benefit-with-adjunct-cariprazine-in-mdd-8f8a72/
- Published: 2026-01-06
- Type: Archive summary (AI-assisted summary of third-party reporting)
- Original outlet: hcplive
- Original report: https://www.hcplive.com/view/early-week-2-response-predicts-sustained-benefit-adjunct-cariprazine-mdd
- Topics: anxiety
- Publisher: TheraNews, operated by AdvancedCare USA Inc.
- Notice: Educational content, not medical, legal, billing or financial advice. Cite the original outlet, not this summary.

---
![Early Week 2 Response Predicts Sustained Benefit with Adjunct Cariprazine in MDD](/uploads/news-images/early-week-2-response-predicts-sustained-benefit-w-20260106110113.png)

---
*Originally reported by hcplive. [Read more](https://www.hcplive.com/view/early-week-2-response-predicts-sustained-benefit-adjunct-cariprazine-mdd)*

---

*Source: [https://www.hcplive.com/view/early-week-2-response-predicts-sustained-benefit-adjunct-cariprazine-mdd](https://www.hcplive.com/view/early-week-2-response-predicts-sustained-benefit-adjunct-cariprazine-mdd)*